Featured companies in Biotech

Get access to the Seedtable database with +15,000 companies (839 from Biotech)
Causaly
Causaly causaly.com
93

Featured

Biomedical research discovery tool.

  • Latest Funding

    $60 Million · Series B

  • Employees

    51 to 100

  • Investors

    Marathon VC, Pentech Ventures, ICONIQ Growth, Index Ventures

  • Business Model

    B2B, SAAS

  • Industries

    Health Tech, AI, Biotech, Pharma

  • Locations

    London

  • Contact

    •••••@causaly.com
    Unlock contact info

CarThera
CarThera carthera.eu
89

Featured

Ultrasound-based medical device to treat a wide range of brain disorders.

  • Latest Funding

    $41 Million · Series B

  • Employees

    1 to 10

  • Investors

    Panakes Partners, EIC Accelerator

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Contact

    •••••@carthera.eu
    Unlock contact info

Complement Therapeutics
Complement Therapeutics complementtx.com
89

Featured

Preclinical stage treatment for geographic atrophy.

  • Latest Funding

    $79 Million · Series A

  • Employees

    1 to 10

  • Investors

    Forbion Capital Partners, Gimv

  • Industries

    Biotech

  • Locations

    London

  • Contact

    •••••@complementtx.com
    Unlock contact info

Biotech by location

List of 69 top tech companies in Biotech

Get access to the Seedtable database with +15k companies (839 from Biotech)
Beacon Therapeutics beacontx.com
89

Oophthalmic gene therapy company to treat blinding retinal illnesses.

  • Latest Funding

    $120 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Syncona Partners LLP

  • Contact

    •••••@beacontx.com
    Unlock contact info

AMSilk amsilk.com
79

Developer of bio-fabricated silk protein materials.

  • Latest Funding

    $27 Million · Series C

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Munich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Novo A/S

  • Contact

    •••••@amsilk.com
    Unlock contact info

Bactolife bactolife.com
79

Producer of gut health binding proteins.

  • Latest Funding

    $33 Million · Series A

  • Industries

    Biotech, Pharma

  • Locations

    Copenhagen

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Bill & Melinda Gates Foundation, Novo A/S

  • Contact

    •••••@bactolife.com
    Unlock contact info

Lindus Health lindushealth.com
79

Clinical trials platform.

  • Latest Funding

    $18 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Valar Ventures, Creandum, Hambro Perks Ltd., Firstminute Capital, Seedcamp, Atomico, Calm/Storm Ventures

  • Contact

    •••••@lindushealth.com
    Unlock contact info

Mnemo Therapeutics mnemo-tx.com
79

Mnemo Therapeutics specializes in biotechnology and life science.

  • Latest Funding

    $90 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@mnemo-tx.com
    Unlock contact info

SparingVision sparingvision.com
79

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

  • Latest Funding

    $53 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Ysios Capital

  • Contact

    •••••@sparingvision.com
    Unlock contact info

AAVantgarde Bio aavantgardebio.com
79

Gene therapies for inherited retinal disorders.

  • Latest Funding

    $65 Million · Series A

  • Industries

    Biotech

  • Locations

    Milan

  • Employees

    1 to 10

  • Investors

    Forbion Capital Partners

  • Contact

    •••••@aavantgardebio.com
    Unlock contact info

Astraveus astraveus.com
79

Automated bioprocessing system for the production of cell and gene therapies.

  • Latest Funding

    $18 Million · Seed

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    AdBio Partners

  • Contact

    •••••@astraveus.com
    Unlock contact info

Gradient Denervation Technologies gradientdenervation.com
79

Medical devices for a transvascular treatment of pulmonary hypertension.

  • Latest Funding

    $15 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Sofinnova Partners, Asabys Partners

  • Contact

    •••••@gradientdenervation.com
    Unlock contact info

Adcendo adcendo.dk
75

Anti-cancer drug developer.

  • Latest Funding

    $34 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Copenhagen

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Ysios Capital, HealthCap

  • Contact

    •••••@adcendo.dk
    Unlock contact info

CatalYm catalym.com
75

Innovative immunotherapies developer for cancer patients.

  • Latest Funding

    $52 Million

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Munich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners, Vesalius Biocapital Partners, Novartis Venture Fund, Bayern Kapital, Coparion

  • Contact

    •••••@catalym.com
    Unlock contact info

Hemab hemab.com
75

Treatments for genetic bleeding disorders.

  • Latest Funding

    $140 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Copenhagen

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    HealthCap, Novo A/S

  • Contact

    •••••@hemab.com
    Unlock contact info

MinervaX minervax.com
75

Vaccine for Group B Streptococcus.

  • Latest Funding

    $23 Million · Series C

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Copenhagen

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    European Investment Bank, Pureos Bioventures, Wellington Partners, Industrifonden

  • Contact

    •••••@minervax.com
    Unlock contact info

Ori Biotech oribiotech.com
75

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

  • Latest Funding

    $100 Million · Series B

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Kindred Capital, Octopus Ventures, Amadeus Capital

  • Contact

    •••••@oribiotech.com
    Unlock contact info

Quell Therapeutics quell-tx.com
75

Quell Therapeutics is a cell therapy company

  • Latest Funding

    $160 Million · Series B

  • Industries

    Health Tech, Edtech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Point72 Ventures, AlbionVC

  • Contact

    •••••@quell-tx.com
    Unlock contact info

Tropic Biosciences tropicbioscience.com
75

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

  • Latest Funding

    $35 Million · Series C

  • Industries

    Agritech, Biotech, Deep Tech, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Future Planet Capital

  • Contact

    •••••@tropicbioscience.com
    Unlock contact info

Umedeor umed.io
75

Platform to automate the clinical studies process.

  • Latest Funding

    $12 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    11.2 Capital, Delin Ventures, Playfair, AlbionVC

  • Contact

    •••••@umed.io
    Unlock contact info

BioLamina biolamina.com
75

Cell therapy development paltform.

  • Latest Funding

    $18 Million · Series A

  • Industries

    Biotech, Deep Tech

  • Locations

    Stockholm

  • Employees

    11 to 50

  • Investors

    Lauxera Capital Partners

  • Contact

    •••••@biolamina.com
    Unlock contact info

Aphea.Bio aphea.bio
71

Developing next generation ‘biopesticides’ based on natural microorganisms.

  • Latest Funding

    $77 Million · Series C

  • Industries

    Agritech, Biotech

  • Locations

    Ghent

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bill & Melinda Gates Foundation, Innovation Industries, SFPIM, Korys, V-Bio Ventures, VIB, Astanor Ventures, PMV

  • Contact

    •••••@aphea.bio
    Unlock contact info

Tagworks Pharmaceuticals tagworkspharma.com
71

Click-to-Release chemistry designed to deliver effective and safe systemic therapies.

  • Latest Funding

    $65 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Arnhem

  • Employees

    1 to 10

  • Investors

    Ysios Capital, New Enterprise Associates

  • Contact

    •••••@tagworkspharma.com
    Unlock contact info

Achilles Therapeutics achillestx.com
68

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

  • Latest Funding

    $68 Million · Series C

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Syncona Partners LLP, Sixth Element Capital, Boxer Capital, Invus, Forbion Capital Partners, AlbionVC

  • Contact

    •••••@achillestx.com
    Unlock contact info

Automata automata.tech
68

Automata is a biotechnology company that provides workflow automation for the life sciences industry.

  • Latest Funding

    $50 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Data and Analytics, Robotics, Manufacturing, Business Intelligence

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Latitude, Isomer Capital, Aldea VC, Local Globe, Octopus Ventures, Hummingbird Ventures, Firstminute Capital, HCVC, Entrepreneur First

  • Contact

    •••••@automata.tech
    Unlock contact info

Charm Therapeutics charmtx.com
68

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

  • Latest Funding

    $50 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Data and Analytics

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    General Catalyst, Khosla Ventures

  • Contact

    •••••@charmtx.com
    Unlock contact info

Egle Therapeutics egle-tx.com
68

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

  • Latest Funding

    $46 Million

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bioqube Ventures

  • Contact

    •••••@egle-tx.com
    Unlock contact info

EnginZyme enginzyme.com
68

Bio alternative to fossil-based and energy–intensive chemical production.

  • Latest Funding

    $22 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Stockholm

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Sofinnova Partners, SEB Venture Capital, Industrifonden

  • Contact

    •••••@enginzyme.com
    Unlock contact info

Eyevensys eyevensys.com
68

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

  • Latest Funding

    $12 Million · Series B

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Pureos Bioventures, Karista

  • Contact

    •••••@eyevensys.com
    Unlock contact info

Kuano kuano.ai
68

Quantum simulation platform for drug discovery.

  • Latest Funding

    $2.2 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B, SAAS

  • Investors

    ACF Investors, Ascension Ventures

  • Contact

    •••••@kuano.ai
    Unlock contact info

LabGenius labgeni.us
68

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

  • Latest Funding

    $25 Million

  • Industries

    Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing

  • Locations

    London

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Kindred Capital, Atomico

  • Contact

    •••••@labgeni.us
    Unlock contact info

Leyden Labs leydenlabs.com
68

Manufacturer of medicines to protect from the threat of respiratory viruses

  • Latest Funding

    $140 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Amsterdam

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    SoftBank Group, GV

  • Contact

    •••••@leydenlabs.com
    Unlock contact info

NorthSea Therapeutics northseatherapeutics.com
68

Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.

  • Latest Funding

    $80 Million · Series C

  • Industries

    Health Tech, Biotech

  • Locations

    Amsterdam

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Ysios Capital, Forbion Capital Partners, Sofinnova Partners, Novo A/S

  • Contact

    •••••@northseatherapeutics.com
    Unlock contact info

OneChain Immunotherapeutics onechaintx.com
68

Therapies for leukaemia based on CAR–T.

  • Latest Funding

    $7.4 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Barcelona

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Invivo Capital Partners

  • Contact

    •••••@onechaintx.com
    Unlock contact info

Pear Bio pearbio.com
68

Cancer treatment predictor software.

  • Latest Funding

    $14 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Octopus Ventures, Fly Ventures

  • Contact

    •••••@pearbio.com
    Unlock contact info

PiLi pili.bio
68

Petroleum-free pigments.

  • Latest Funding

    $16 Million · Series A

  • Industries

    Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bpifrance, Elaia

  • Contact

    •••••@pili.bio
    Unlock contact info

ReViral reviral.co.uk
68

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

  • Latest Funding

    $44 Million · Series C

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Andera Partners, Novo A/S

  • Contact

    •••••@reviral.co.uk
    Unlock contact info

Tissium tissium.com
68

Niodegradable sealants and adhesives for wound closure.

  • Latest Funding

    $55 Million · Series D

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Credit Mutuel, CM-CIC Capital Finance, Omnes Capital, Cathay Innovation, Sofinnova Partners, Bpifrance, Karista

  • Contact

    •••••@tissium.com
    Unlock contact info

Turbine turbine.ai
68

Platform to understand the inner mechanisms of cancer enabling the discovery of novel therapies.

  • Latest Funding

    $6 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Budapest

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    MassMutual Ventures, Day One Capital, Accel, Atlantic Labs

  • Contact

    •••••@turbine.ai
    Unlock contact info

Hypervision Surgical hypervisionsurgical.com
68

Precision software for eye surgery.

  • Latest Funding

    $8.1 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Redalpine

  • Contact

    •••••@hypervisionsurgical.com
    Unlock contact info

Anocca anocca.com
68

Personalized immunotherapy.

  • Latest Funding

    $27 Million · Debt Financing

  • Industries

    Health Tech, Biotech

  • Locations

    Stockholm

  • Employees

    11 to 50

  • Investors

    European Investment Bank

  • Contact

    •••••@anocca.com
    Unlock contact info

Affibody affibody.com
68

Biotech company focused on developing products for therapy, diagnostic imaging, and other applications.

  • Latest Funding

    $21 Million · Debt Financing

  • Industries

    Biotech

  • Locations

    Stockholm

  • Employees

    11 to 50

  • Investors

    European Investment Bank

  • Contact

    •••••@affibody.com
    Unlock contact info

Kiro kiro.bio
68

AI-dirven clinical biology.

  • Latest Funding

    $15 Million · Series A

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    Sofinnova Partners

  • Contact

    •••••@kiro.bio
    Unlock contact info

Multiomic Health multiomic.uk
68

Precision therapeutics discovery platform.

  • Latest Funding

    $6.2 Million · Seed

  • Industries

    Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures

  • Contact

    •••••@multiomic.uk
    Unlock contact info

ARTBIO artbio.com
68

Clinical-stage radiopharmaceutical biotech.

  • Latest Funding

    $23 Million · Seed

  • Industries

    Biotech

  • Locations

    Oslo

  • Employees

    11 to 50

  • Investors

    F-Prime Capital

  • Contact

    •••••@artbio.com
    Unlock contact info

Tenpoint Therapeutics tenpointtherapeutics.com
68

Restore sight by replacing engineered cell-based therapeutics.

  • Latest Funding

    $70 Million · Series A

  • Industries

    Biotech

  • Locations

  • Employees

    11 to 50

  • Investors

    British Patient Capital, F-Prime Capital, Eight Roads Ventures, Sofinnova Partners

  • Contact

    •••••@tenpointtherapeutics.com
    Unlock contact info

Bind-X bind-x.com
68

Manufacturer of sustainable biological binding of materials.

  • Latest Funding

    $11 Million · Series B

  • Industries

    Biotech, Deep Tech

  • Locations

    Munich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    HG Ventures, High-Tech Gründerfonds

  • Contact

    •••••@bind-x.com
    Unlock contact info

Corteria Pharmaceuticals corteriapharma.com
68

Interceptive therapies for heart failure subpopulations.

  • Latest Funding

    $70 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    OrbiMed, Invivo Capital Partners, Omnes Capital

  • Contact

    •••••@corteriapharma.com
    Unlock contact info

Mironid mironid.com
67

Biopharma developing small molecule therapeutics.

  • Latest Funding

    $38 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Glasgow

  • Employees

    11 to 50

  • Investors

    EIC Accelerator, Scottish Investment Bank

  • Contact

    •••••@mironid.com
    Unlock contact info

Castor EDC castoredc.com
64

Cloud-based clinical data platform.

  • Latest Funding

    $45 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Amsterdam

  • Employees

    101 to 250

  • Business Model

    B2B, SAAS

  • Investors

    Eight Roads Ventures, Inkef Capital

  • Contact

    •••••@castoredc.com
    Unlock contact info

Epsilogen epsilogen.com
64

Immuno-oncology company treats cancer with antibodies.

  • Latest Funding

    $42 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Epidarex Capital, AlbionVC, Novartis Venture Fund

  • Contact

    •••••@epsilogen.com
    Unlock contact info

Labster labster.com
64

Labster is an e-learning company that offers virtual laboratory simulations based on mathematical algorithms.

  • Latest Funding

    $47 Million · Series C

  • Industries

    Edtech, Hardware, AR / VR, Biotech

  • Locations

    Copenhagen

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Balderton Capital, Northzone, A16Z, Educapital, Swisscom Ventures, AENU, Nordic Makers

  • Contact

    •••••@labster.com
    Unlock contact info

Mainstay Medical mainstay-medical.com
64

Manufacturer of medical devices for mechanical Chronic Low Back Pain (CLBP).

  • Latest Funding

    $50 Million · Debt Financing

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Dublin

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Oxford Finance LLC, Armentum, Sofinnova Partners, Fountain Healthcare Partners, Seventure Partners

  • Contact

    •••••@mainstay-medical.com
    Unlock contact info

Oncopeptides oncopeptides.com
64

Innovative therapy for difficult-to-treat hematological diseases.

  • Latest Funding

    $31 Million

  • Industries

    Biotech, Deep Tech

  • Locations

    Stockholm

  • Employees

    251 to 500

  • Business Model

    B2C

  • Investors

    European Investment Bank

  • Contact

    •••••@oncopeptides.com
    Unlock contact info

PathoQuest pathoquest.com
64

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

  • Latest Funding

    $17 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Eurazeo, Norgine Ventures, Verve Ventures

  • Contact

    •••••@pathoquest.com
    Unlock contact info

Precirix precirix.com
64

Manufacturer of radio-immunotherapeutic drugs for cancer patients.

  • Latest Funding

    $88 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Brussels

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Gimv, Forbion Capital Partners, BioMedPartners, HealthCap, V-Bio Ventures, Novo A/S, Inkef Capital

  • Contact

    •••••@precirix.com
    Unlock contact info

Step Pharma step-ph.com
64

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

  • Latest Funding

    $41 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    AGORANOV, Bpifrance, Idinvest Partners, Hadean Ventures

  • Contact

    •••••@step-ph.com
    Unlock contact info

SynOx Therapeutics synoxtherapeutics.com
64

Developer of treatment for diffuse tenosynovial giant cell tumors.

  • Latest Funding

    $44 Million

  • Industries

    Health Tech, Biotech

  • Locations

    Dublin

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners, Gimv, Medicxi, HealthCap

  • Contact

    •••••@synoxtherapeutics.com
    Unlock contact info

Tubulis tubulis.com
64

Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.

  • Latest Funding

    $65 Million

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Munich

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    BioMedPartners, Andera Partners, Seventure Partners, Bayern Kapital, Coparion, High-Tech Gründerfonds

  • Contact

    •••••@tubulis.com
    Unlock contact info

Univercells univercells.com
64

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

  • Latest Funding

    $44 Million

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Brussels

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    TheClubDeal

  • Contact

    •••••@univercells.com
    Unlock contact info

LinKinVax linkinvax.com
64

Protein-based vaccines.

  • Latest Funding

    $7.8 Million · Series A

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    In-Q-Tel

  • Contact

    •••••@linkinvax.com
    Unlock contact info

Basecamp Research basecamp-research.com
64

Protein discovery research and manufacturing.

  • Latest Funding

    $20 Million · Series A

  • Industries

    Biotech, Deep Tech

  • Locations

    London

  • Employees

    11 to 50

  • Investors

    SYSTEMIQ

  • Contact

    •••••@basecamp-research.com
    Unlock contact info

Bea Fertility beafertility.com
64

At-home fertility treatment.

  • Latest Funding

    $3.2 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    Octopus Ventures, QVentures, Calm/Storm Ventures

  • Contact

    •••••@beafertility.com
    Unlock contact info

Ariceum Therapeutics ariceum-therapeutics.com
62

Diagnosis and treatment of hard-to-treat cancers.

  • Latest Funding

    $25 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Berlin

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Andera Partners, HealthCap, Pureos Bioventures, Earlybird Venture Capital

  • Contact

    •••••@ariceum-therapeutics.com
    Unlock contact info

Noema Pharma noemapharma.com
62

Clinical-stage central nervous system (CNS) technology.

  • Latest Funding

    $110 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Basel

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners, BioMedPartners, Sofinnova Partners

  • Contact

    •••••@noemapharma.com
    Unlock contact info

Xeltis xeltis.com
62

Restorative cardiovascular devices.

  • Latest Funding

    $14 Million · Series D

  • Industries

    Hardware, Biotech

  • Locations

    Eindhoven

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Ysios Capital, EIC Accelerator

  • Contact

    •••••@xeltis.com
    Unlock contact info

Amolyt Pharma amolytpharma.com
62

Peptides for the treatment of rare endocrine and related diseases.

  • Latest Funding

    $140 Million · Series C

  • Industries

    Biotech

  • Locations

    Lyon

  • Employees

    11 to 50

  • Investors

    Intermediate Capital Group, Sofinnova Partners

  • Contact

    •••••@amolytpharma.com
    Unlock contact info

Chemify chemify.io
62

Chemical discovery digitisation platform.

  • Latest Funding

    $43 Million · Series A

  • Industries

    Biotech, Manufacturing

  • Locations

    Glasgow

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Horizons Ventures, BlueYard Capital

  • Contact

    •••••@chemify.io
    Unlock contact info

Sensorion sensorion.com
62

Therapeutic treatment for hearing loss disorders.

  • Latest Funding

    $38 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Montpellier

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Invus, Sofinnova Partners

  • Contact

    •••••@sensorion.com
    Unlock contact info